Literature DB >> 16025114

Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.

Michael A Ko1, Carla O Rosario, John W Hudson, Sarang Kulkarni, Aaron Pollett, James W Dennis, Carol J Swallow.   

Abstract

The polo-like kinase Plk4 (also called Sak) is required for late mitotic progression, cell survival and postgastrulation embryonic development. Here we identified a phenotype resulting from Plk4 haploinsufficiency in Plk4 heterozygous cells and mice. Plk4+/- embryonic fibroblasts had increased centrosomal amplification, multipolar spindle formation and aneuploidy compared with wild-type cells. The incidence of spontaneous liver and lung cancers was approximately 15 times high in elderly Plk4+/- mice than in Plk4+/+ littermates. Using the in vivo model of partial hepatectomy to induce synchronous cell cycle entry, we determined that the precise regulation of cyclins D1, E and B1 and of Cdk1 was impaired in Plk4+/- regenerating liver, and p53 activation and p21 and BubR1 expression were suppressed. These defects were associated with progressive cell cycle delays, increased spindle irregularities and accelerated hepatocellular carcinogenesis in Plk4+/- mice. Loss of heterozygosity occurs frequently (approximately 60%) at polymorphic markers adjacent to the PLK4 locus in human hepatoma. Reduced Plk4 gene dosage increases the probability of mitotic errors and cancer development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025114     DOI: 10.1038/ng1605

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  91 in total

1.  Centriole duplication: A lesson in self-control.

Authors:  Andrew J Holland; Weijie Lan; Don W Cleveland
Journal:  Cell Cycle       Date:  2010-07-27       Impact factor: 4.534

Review 2.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

Review 3.  The Janus soul of centrosomes: a paradoxical role in disease?

Authors:  Maddalena Nano; Renata Basto
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

4.  SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.

Authors:  Takanori Nakamura; Haruo Saito; Mutsuhiro Takekawa
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Plk4 is required for cytokinesis and maintenance of chromosomal stability.

Authors:  Carla O Rosario; Michael A Ko; Yosr Z Haffani; Rebecca A Gladdy; Jana Paderova; Aaron Pollett; Jeremy A Squire; James W Dennis; Carol J Swallow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-26       Impact factor: 11.205

6.  The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.

Authors:  Andrew J Holland; Daniele Fachinetti; Quan Zhu; Manuel Bauer; Inder M Verma; Erich A Nigg; Don W Cleveland
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

Review 7.  Alternative functions of core cell cycle regulators in neuronal migration, neuronal maturation, and synaptic plasticity.

Authors:  Christopher L Frank; Li-Huei Tsai
Journal:  Neuron       Date:  2009-05-14       Impact factor: 17.173

8.  The SCF Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication.

Authors:  Gregory C Rogers; Nasser M Rusan; David M Roberts; Mark Peifer; Stephen L Rogers
Journal:  J Cell Biol       Date:  2009-01-26       Impact factor: 10.539

9.  Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability.

Authors:  Andrew J Holland; Weijie Lan; Sherry Niessen; Heather Hoover; Don W Cleveland
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

10.  Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro.

Authors:  Carmen H Coxon; Katrina A Bicknell; Fleur L Moseley; Gavin Brooks
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.